Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity

U Garbin, AF Pasini, C Stranieri, S Manfro… - Pharmacological …, 2007 - Elsevier
Asymmetric dimethylarginine (ADMA) has been reported to affect the synthesis of nitric oxide
(NO) in endothelial cells by inhibiting endothelial NO synthase (eNOS) activity and to cause …
被引用次数：49 相关文章

Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.

U Garbin, AF Pasini, C Stranieri, S Manfro… - Pharmacological …, 2007 - europepmc.org
Asymmetric dimethylarginine (ADMA) has been reported to affect the synthesis of nitric oxide
(NO) in endothelial cells by inhibiting endothelial NO synthase (eNOS) activity and to cause …

Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity

U Garbin, AF Pasini, C Stranieri, S Manfro… - Pharmacological …, 2007 - infona.pl
Asymmetric dimethylarginine (ADMA) has been reported to affect the synthesis of nitric oxide
(NO) in endothelial cells by inhibiting endothelial NO synthase (eNOS) activity and to cause …

Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity

U Garbin, AF Pasini, C Stranieri… - Pharmacological …, 2007 - pubmed.ncbi.nlm.nih.gov
Asymmetric dimethylarginine (ADMA) has been reported to affect the synthesis of nitric oxide
(NO) in endothelial cells by inhibiting endothelial NO synthase (eNOS) activity and to cause …

[引用][C] Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity

U GARBIN, A FRATTA PASINI, C STRANIERI… - Pharmacological …, 2007 - Elsevier